<DOC>
	<DOCNO>NCT02926326</DOCNO>
	<brief_summary>An open-label , single-sequence study evaluate effect azithromycin BCT197 exposure healthy male subject .</brief_summary>
	<brief_title>The Effect Azithromycin BCT197 Exposure Healthy Male Volunteers</brief_title>
	<detailed_description>This open study conduct healthy male subject single centre . Each subject participate screen visit 2 study period . At first study period , subject receive single dose BCT197 study period 2 , subject receive 3 daily dos azithromycin single dose BCT197 .</detailed_description>
	<criteria>Inclusion Criteria Healthy male subject . Nonsmokers ( include ecigarettes ) . Body mass index ( BMI ) ≥ 18 ≤ 30 kg/m2 . Willing use highly effective barrier contraception method . Male subject must donate sperm study . Exclusion Criteria Any subject preexist active skin disease . Laboratory value screen deem clinically significant . Volunteers abnormal liver function test . 12 Lead ECG QTcF &gt; 450 msec . Allergy BCT197 excipients . Known hypersensitivity intolerance azithromycin . Taking medication know cause QTc prolongation . Positive human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C. Any clinically significant illness within 30 day prior study drug administration . Volunteers , opinion Investigator , unsuitable participation study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Healthy Male volunteer</keyword>
</DOC>